Lantern Spin-Outs as Separate AI Company
Lantern has established a separate company, Open-Medicine AI, to commercialize its withZeta.ai platform by licensing technology and assets, aiming to leverage the projected growth in AI drug discovery.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day